Desmond Tutu HIV Centre

Desmond Tutu HIV Centre

Interactive Data Dashboards

Track the HIV & TB response

Key indicators, province breakdowns and downloadable graphs.

  • US funding cuts imperil search for HIV vaccine

    A groundbreaking project to study potential HIV vaccines in several African countries has been derailed by an abrupt cut in funding from the United States government. As a result, several promising vaccine candidates might not be tested in clinical trials. Catherine Tomlinson reports.

    ·

  • HIV prevention shots and vaginal rings – this is why SA pilots have not yet started

    Last year Spotlight reported that pilot projects testing out a new HIV prevention injection and a vaginal ring in South Africa would start early in 2023. Yet, as delegates gathered for the SA AIDS Conference in Durban last week, those pilots hadn’t yet started. Alicestine October and Elri Voigt have the latest on the state…

    ·

  • Major study turns spotlight on formula milk industry

    The scientific evidence that exclusive breastfeeding is best for infants is very strong. Yet, some baby milk formula companies continue to use questionable methods to create demand for their products, thereby undermining breastfeeding. Elsabé Brits explores this and spoke to experts based on a series of articles published in The Lancet.

    ·

  • Vaginal ring to prevent HIV safe to use in late pregnancy and while breastfeeding

    A vaginal ring used to prevent HIV infection is safe to use during late pregnancy and while breastfeeding, according to findings presented at a major international HIV conference in Seattle in the United States. The news comes as South Africa prepares for a likely national rollout of the ring and as more research confirms the…

    ·

  • AIDS 2022: How to tailor HIV prevention efforts to people’s needs

    One of the hot topics at the recently concluded AIDS 2022 conference held in Montreal, Canada, was how HIV prevention interventions such as pills or injections that prevent HIV infection should be made available to different groups of people. Tiyese Jeranji spoke to some local experts and an activist about the rich set of discussions.

    ·

  • Study suggests potential role for bnAbs in treating kids living with HIV

    Broadly neutralising antibodies (bnAbs) are one of the most active and exciting areas in HIV research. Last year Spotlight reported on a “proof of concept” study showing that a specific bnAb can successfully prevent infection with certain strains of HIV. Now, we also have intriguing findings suggesting that bnAbs may have a role to play…

    ·

  • Why broadly neutralising antibodies might be the next big thing in HIV

    We know antiretroviral therapy can prevent HIV infection, but can natural biological substances do the same? The results of a recent scientific trial have answered this question: Yes, using broadly neutralising antibodies. But what are broadly neutralising antibodies? How do they work? And when will the average person get access to them? Amy Green breaks…

    ·

  • Where are we in the race for a HIV vaccine?

    While progress in the race for effective COVID-19 vaccines has been rapid and impressive, an effective HIV vaccine remains elusive. As part of Spotlight’s World AIDS Day 2020 coverage, Kathryn Cleary asks two of South Africa’s top vaccine researchers to update us on where we are in the race for an HIV vaccine.

    ·